Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Turn to the experienced analysts and deep wells of data at Informa Pharma Intelligence for all your clinical trial data needs. Our teams of subject matter experts deliver essential clinical trial data analysis, using data drawn from the most robust clinical trial database available.
Your free Pink Sheet pack includes essential updates on shifts in clinical trials, including the articles:
We highlight the trial activity since guidance was issued by the FDA in 2009 and look at relevant trends. You will see:
Pharma R&D Annual Review 2019 is based on the stats and data from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects, this whitepaper contains the whole nine yards:
The ball is in your court: tap into the industry expertise and experience of Ian Lloyd, backed by the rock-solid data from Pharmaprojects download Pharma R&D Annual Review 2019 from Citeline, today.
Listen to our special Spotify playlist while you read. We hope you enjoy this tongue-in-cheek collection of songs, specially curated as the perfect accompaniment to the Pharma R&D Annual Review 2019.
Medtech Insight
Updates to the EU Medical Devices Regulation are just weeks away from becoming a reality for manufacturers and suppliers. Medtech Insight delivers expert insights into the latest developments and what they could mean for your business.
Topic Medtech
In Vivo, Pink Sheet
The COVID-19 pandemic has brought about significant manufacturing and distribution challenges and opportunities for Pharma. Seize new opportunities and avoid risk with the strategic commercial and regulatory intelligence you need to stay competitive by subscribing to Pink Sheet and In Vivo.
Topic Strategy
Citeline, Trialtrove
Over the past five years, our analysis of completed trials consistently observed growth trends.
Topic Coronavirus Clinical Trials
Pink Sheet
Drug manufacturers still have a variety of ways to limit the impact of the Biden administration’s historic decision. Whether the huge political loss for industry translates into more than just headline-risk or faster global COVID vaccination remains to be seen. It's also not clear whether it’s an ominous sign for other industry battles in the US, including the drug pricing debate.
Medtech Insight
Keep current with comprehensive coverage of today’s deals and their impact on the future of the medtech landscape. Medtech Insight brings you insight and analysis of significant recent deals and what they mean for your strategy. Stay in the know with your free Quarterly Roundup.
Topic Medtech
HBW Insight
As Germany remains in lockdown, sales in its OTC market struggle to return to pre-pandemic levels, according to new data from Sempora Consulting. Meanwhile, COVID-related trends for wellness and online shopping endure, indicating some strategic priorities for OTC firms operating in the country.
Scrip
Pfizer said it expects to generate $26bn in annual revenues from the COVID-19 vaccine BNT162b2 and is leveraging the platform to build out a durable business.
Citeline Study Feasibility
This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility. Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.
Topic Clinical Trials
Medtech Insight
The settlement resolves allegations the neurosurgeon collected kickbacks both for using Medtronic devices and for buying devices through his own distributorships.
Scrip
Expanded indications will be key for Novartis's Beovu and a successful diabetic macular edema trial has provided a fillip, a week after the wet AMD-approved drug posted a 44% slump in sales.
Citeline, Biomedtracker, Pharma Consulting, Datamonitor Heal...
Catch up on any missed COVID-19 24 hour webinar sessions
Topic Cardiovascular Coronavirus
Generics Bulletin
As India sees a consistent rise in daily cases and deaths due to COVID-19, the off-patent industry is stepping up to make drugs affordable and available. Zydus Cadila is seeking approval for virafin, while Natco has applied for molnupiravir approval. Vaccine production and availability has also come under focus.
Pharmaprojects, Citeline
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Medtech Insight
The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.
Generics Bulletin
Attendees to Medicines for Europe’s virtual summit on biosimilars heard how learning from experiences across Europe can allow individual countries to build a toolbox of policies to help create a sustainable biosimilars market.
Pink Sheet
13 May 2021
Pink Sheet
13 May 2021
HBW Insight
13 May 2021
HBW Insight
13 May 2021
Generics Bulletin
13 May 2021
Generics Bulletin
13 May 2021
Generics Bulletin
13 May 2021
Generics Bulletin
13 May 2021
Medtech Insight
13 May 2021
Scrip
13 May 2021
Pink Sheet
13 May 2021
Medtech Insight
13 May 2021
HBW Insight
13 May 2021
Pink Sheet
12 May 2021
Pink Sheet
12 May 2021
Over 450,000 investigators from 170,000+ sites in 180+ countries, all with clinical trial experience, at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove.
Key benefits:
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
